John Jordan | VP, Investor Relations and Corporate Communications |
Jonathan Violin | CEO, President & Director |
Kristian Humer | CFO, Chief Business Officer, Principal Financial Officer & Principal Accounting Officer |
Christopher Howerton | Jefferies |
Thomas Smith | SVB Leerink |
Laura Chico | Wedbush Securities |
Rami Katkhuda | LifeSci Capital |
Jason Butler | JMP Securities |
Welcome to the Viridian Therapeutics First Quarter 2022 Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, John Jordan, Vice President of Investor Relations and Corporate Communications at Viridian. Please go ahead, sir.
Thank you, Debbie.